EVENTS

This Summit is focused on Cancer Immunotherapy, the most promising new cancer treatment approach since the development of the first chemotherapies. This summit brings together leading industry professionals in order to expand the scientific horizons of Cancer Immunotherapy, and discuss the latest advances and improvements in research and development.

We will discuss key findings, including critical insights, as well as recommendations for accelerating development in the field.

Key Practical Learning Points of the Summit:

    Advanced methods, technological developments and strategies in Cancer Immunotherapy
    The success of antibodies in therapeutics and engineering
    The true potential of the next generation immune checkpoint pathways
    Revolutionary cancer treatment with personalised cancer vaccines
    Reinforcing anti-tumour immunity
    Biomarkers’ responses
    Managing unique immune-mediated adverse reactions and toxicity effects
    Progressive genetic engineering techniques
    Preclinical and clinical progress in Cancer Immunotherapy
    CAR T-Cell Therapy: A game changer in cancer treatment
    Regulatory aspects of the EU and the rest of the world

India Lab expo, India’s largest exhibition on laboratory, scientific, analytical and biotechnology sector attracts international as well as Indian manufacturers and distributors. Decision makers from sectors like hospitals, diagnostic labs, oil & petroleum, chemical, cosmetics and Government departments can be met at the tradeshow.

The Precision Medicine and Biomarkers Leaders Summit will provide a forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.

More intimate roundtable discussions will also provide an opportunity for you and your peers to cover, in detail, issues such as fulfilling the potential of big data, conducting precision medicine clinical trials and advancing liquid biopsies to the clinic.

Ensuring Compliant Handling and Protection of Data, both Patient & Corporate, through Risk-Based Approaches to 3rd Party Assessments, Strong Internal Controls & Proactive Prevention of Breaches through Vulnerability Testing & Incident Response Management

Corporations large and small face the increasingly difficult task of securing internal networks against threats and vulnerabilities, both from external and internal sources, a challenge which is of considerable concern to life science information security executives, responsible for the safety and privacy of both patient as well as corporate data. New patient data privacy regulations enacted in Europe are of particular concern as corporations look to work and collaborate with research facilities and patients in the development of the next generation of medical products. With data being shared across networks, through big data cloud applications and across continents, the ability to secure information is of paramount importance.

From vetting third party partners, from software and security measures to contract research organizations, information security executives within the life sciences industry are facing a time of considerable change and threat. Taking a risk based approach to securing networks against threats; from the creation of strong internal controls to guide staff, to the regular conduct of penetration testing and incident response programming, executives must develop a responsive and agile team. Unlike traditional information security conferences, this educational platform will focus on the specific needs of life science companies, providing a unique opportunity for two engaging days of education and knowledge share at an industry peer level.

As the global healthcare industry grows, temperature controlled logistics rapidly evolves along with it. With ever-changing global regulatory requirements, a more diverse array of biopharma products entering the supply, and new technology emerging daily; companies face the challenge of constantly adapting their supply chain processes to stay ahead of the curve.

Responding to the evolution within the industry, the 15th Annual Global Forum has changed as well with an updated look, color scheme, and topic focus. This elevated brand identity allows us to follow suit with the industry, remain at the forefront of innovation, and embody the high level of quality the event delivers each year.

Welcome to the Annual International Conference on Pharmacology and Pharmaceutical Sciences (PHARMA). The conference aims to explore pharmacology, its relation with pharmaceutical sciences and application in the development of healthcare products.

Through sharing and networking, PHARMA 2017 will provide an opportunity for researchers, practitioners and educators to exchange research evidence, practical experiences and innovative ideas on issues related to pharmacology and pharmaceutical sciences.

The global injectable drug delivery market is expected to grow at 12.5% CAGR from now until 2022, reaching USD $797.22 billion by 2022!

While pre-filled syringes and closely related injectable devices have been around for decades, both innovations and regulatory environment are evolving rapidly. Drug and device developers need to catch up to ensure a safe and quality injection system.

Building on previous success, the 7th edition of PFS & Injectables is returning to San Diego in September. With our growing engaged community, you can expect interactive discussions and case studies to help you enhance your device quality with evolving therapeutics needs.

The Generis American Pharma Outsourcing Summit sets the standard on how the industry should connect and exchange ideas.

The summit is designed to provide pharmaceutical outsourcing executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics. This unique summit brings together manufacturing and supply chain-focused leaders involved in the business of pharmaceutical outsourcing. Network with over 150 of your peers as we explore strategies to maximize efficiency while remaining compliant in an ever-evolving environment.

Over 250 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations, case studies and panel discussions focussed on the innovative application of artificial intelligence in drug development and clinical research, alongside novel diagnostic tools using artificial intelligence.

Including 3 Interactive Streams:

    Artificial Intelligence (AI) in Drug Discovery and Development
    Artificial Intelligence (AI) in Big Data and Clinical Research Development
    Diagnostics and Medical Imaging in Healthcare

Co-located with our 15th Pharmaceutical IT Congress

14 pre-scheduled one to one meetings, exhibition spaces and informal networking opportunities

we.CONECT’s annual MES & Process Minds is gathering global players and local hidden champions of the pharmaceutical industry to explore latest developments in the field of MES. The conference is an international knowledge exchange platform bringing together all stakeholders who play an active role in the MES scene and has become the calendar event amongst MES professionals.

we.CONECT’s annual TRACKTS! 2017 – Track & Trace redefined – Serialization Now! is gathering global players and local hidden champions of the pharmaceutical industry to explore the latest developments in the field of serialization. The conference is an international knowledge exchange platform bringing together all stakeholders playing an active role in the serialization process and has become the calendar event amongst serialization professionals.

BIO is pleased to announce its sixth annual Patient and Health Advocacy Summit held on October 2-3, 2017 at the Mayflower Hotel in Washington, DC. This event brings together patient advocacy organizations, academia, regulators, biotechnology industry, and other stakeholders for two days of robust programming to discuss timely policy issues and share best practices. The Summit also provides invaluable networking opportunities to advance partnership among stakeholders in the healthcare ecosystem. Last year, the Summit convened over 320 attendees from nearly 200 different organizations.

MAGHREB PHARMA Expo welcomes more than 2100 professional visitors of pharamceutic production during 3 days and more than 190 international exhibitors from 25 countries. More than 40 industrial seminars are organized during the fair. Participating in MAGHREB PHARMA Expo is the most profitable way to establish new partnerships, meet your local and international suppliers and stay informed of the latest trends in the industry.

The fair  covers the entire spectrum of pharmaceutical production, from ingredients to secondary packaging through clean rooms and production lines, offering all products and services covering the entire supply chain for medicines, medical devices and food supplements.

This Festival is for anyone generating, using, or studying genomic information. It has been designed to offer insights and value for the full breadth of the genomics community – from academia, biopharma, healthcare organizations, investment firms, patient organizations and solution providers.

As our Flagship event, The Festival of Genomics Boston provides a unique opportunity to meet with the whole of the genomics community, in an environment carefully constructed to facilitated networking, learning and business growth.

DDIP Munich aims to provide a key networking event that will offer an unprecedented opportunity to gain insights from key presenters and thought leaders in the field of Medicinal Chemistry, Computational Biology and Drug Designing from across Europe.

Throughout the course of the two day programme, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions of scientists and researchers from the international pharmaceutical, academic and research communities. With over 120 attendees expected, this multi-track event will allow delegates unrestricted access to all event tracks and sessions and help them in exploring innovative technologies and approaches that can be used to overcome drug development challenges.

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

5 Interactive Streams:

    Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
    Personalised Medicine, Companion Diagnostics & Patient Testing
    Innovations In Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
    Biomarker in Clinical Development & Clinical Trials
    Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

300 delegates representing leading sequencing centres, global pharmaceutical organisations and world-renowned research institutions

35 presentations and case studies focused on the key developments in sequencing, analysis and bioinformatics, clinical and therapeutic applications, epigenetics and genomics.

Following extensive research with our esteemed advisory board, for 2017 we have revamped our 4 interactive streams:

    NGS Technologies and Key Therapeutic Applications
    Clinical Applications of NGS – Based Genomic Profiling And Molecular Diagnostics
    – PART 2 – NGS Data Analysis & Management
    Single Cell Analysis Technologies, Informatics & Data Handling
    Single Cell ‘Omics & Applications in Therapeutics

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

300 attendees working within single cell analysis, genomics, transcriptomics and proteomics

Over 25 case studies, presentations and panel discussions

Together with our NGS Asia Congress there will be 4 interactive streams:

    Single Cell Analysis Technologies, Informatics & Data Handling
    Single Cell ‘Omics & Applications in Therapeutics
    NGS Technologies and Key Therapeutic Applications
    Clinical Applications of NGS – Based Genomic Profiling And Molecular Diagnostics
    – PART 2 – NGS Data Analysis & Management

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

This two day congress, co-located with the 7th Annual Next Generation Sequencing & Clinical Diagnostics Asia Congress and the 4th Annual Microbiology and Infectious Diseases Asia Congress, will bring together over 300 experts from Asia, Australasia, the US and Europe to discuss the key topics and updates in single cell research.

It’s time to stop talking, and start doing. Australian pharma is in desperate need of a business model which starts with the customer – not the medicine. Our focus at eyeforpharma Sydney 2017 will be relentless and comprehensive, with practical "how to" and "how not to" guides to deliver a real customer experience, develop trust and get in sync with what patients want. Join us for 2 days of expert presentations, heated panel discussions, interactive exhibitions and exclusive networking. We will cover:

    Co-create with customers to design mutual success plans: Develop strong partnerships at the design stage with HCPs and patients
    Stop shouting louder: Generate pull-communication, enable personalisation and change your customer relationship dynamics
    It’s the ecosystem, stupid: Take responsibility for cultivating the pharma-customer-patient ecosystem to drive engagement, adherence and brand loyalty
    From customer service to customer experience: Move from tactical to strategic in your business planning approach - and redefine your customer interactions
    The commercial team of the future: Understand how you should invest now to ensure you are a step ahead of technology and regulatory imperatives

300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

35+ presentations and case studies focusing on the key developments in clinical microbiology, microbial genomics, molecular diagnostics and infectious diseases

4 interactive streams:

    Detection Technologies, Molecular Diagnostics and Microbiome Analysis
    Clinical Microbiology
    Microbial Genomics And Genome Sequencing
    Infectious Diseases

Oxford Global Conferences are proud to present the 4th Annual Microbiology & Infectious Diseases Asia Congress, taking place on the 10-11 October 2017 in Singapore. The event is a unique opportunity for over 300 experts working in molecular diagnostics, microbiology, genome sequencing technologies and infectious diseases to hear essential insights into the latest developments and research results that shape the current landscape of the industry.

Back by popular demand our 4th Annual Microbiology and Infectious Disease Asia Congress will once again be co-located with both our 7th Annual Next Generation Sequencing & Clinical Diagnostics Asia Congress and 5th Annual Single Cell Analysis Asia Congress.

With no approved treatment and growing patient population nonalcoholic steatohepatitis (NASH) is a huge unmet medical need.

The NASH Summit is Europe’s definitive forum which exists to solve the challenges drug developers face from discovery to late stage clinical development. This comprehensive forum will help you identify and validate novel targets, better recapitulate human NASH disease preclinically and robustly diagnose patient populations.

With a specific focus on the most pressing drug development challenges the this NASH conference will dive into a greater depth of content than any other meeting, ensuring you leave bursting with insights, ideas and solutions to propel your NASH pipeline forward.

Join your peers at NASH Summit to learn from  and engage with leading experts and accelerate your NASH drug candidate development.

With new treatment options available and an increasingly better understanding of the pathophysiology of skin diseases, the dermatology drug development space is now on the verge of a therapeutic revolution. This tremendous environment of opportunity is driving a lot of investment to innovate and bring better and more efficient therapies to market.

The Dermatology Drug Development Summit provides a forum for industry experts to share data and best practice to accelerate the success of game-changing derma products and ensure a better quality of life for patients with chronic conditions.

Join your peers to tackle specific challenges you face in developing these drugs – from strategic concerns, to R&D, clinical development and regulatory hurdles – and uncover the details behind the latest developments in this space.

ExL’s 8th Clinical Quality Oversight Forum focuses on ensuring trial integrity by effectively assessing, optimizing and managing the quality of clinical vendors and sites. This forum acts as the annual gathering for clinical quality, operations, management and audit professionals to engage and candidly share their experiences, struggles, obstacles, and achievements when working with varying clinical partners, including CROs and investigator sites. Learn from this experienced group and take away proven, results-driven, risk-based strategies for optimizing your company’s clinical vendor and site oversight approach.

Genesis Clinical Trial (GCT) brings together leaders from Pharma, Biotech and Academia to share case studies and best practices on effective clinical trial management and vendor oversight. The program focuses on key issues and opportunities in the clinical trial industry, including Patient Recruitment, Site Selection, Data Integration, Existing Data Sources, Mobile Tech, Project Management, Outsourcing, Vendor Management, Budgeting and Contracting, Risk-Based Monitoring, Recruitment and Retention.

The GCT is a combination of case study presentations, panel discussions and one to one meetings in order to maximize interactions between industry experts. Genesis Clinical Trials brings together the right people on meeting table to do business. With our strong dedication and unmatched business intelligence, we offer nothing but the best for you to take your business to the next level. This is what makes our clients come back each year to find new people to do business with.

Meetings International absolutely delighted to welcome you to the Global Proteomics Conference which will be held in Dubai, UAE on October 12-13, 2017. With a theme of “Improved Understanding, Latest Advances And Future Prospects In The Field Of Proteomics.”

Meetings International provides a Global Platform for Biochemistry Professionals, Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

We are looking forward to provide you with a superb environment in global proteomics to present, discuss and advance your proteomic research. The world class scientific programme will consolidate existing knowledge while at the same time increase your awareness of leading edge and forward looking advances in the field. It also includes previous milestone developments in proteomics, the current state of the art as well as newly arising areas and opportunities and application of proteomics in clinical trials, therapeutic protein production and disease diagnosis, including opportunities for brainstorming and networking to provide solutions in global healthcare.

We look forward to seeing/welcoming you in Proteomics Meeting 2017 for an experience of a lifetime.

The Fourth Annual International Pharmaceutical Distribution Conference (IPDC) will bring together pharmaceutical distributors, manufacturers and supply chain executives from around the globe to discuss business practices and emerging strategies that preserve patient safety, enhance security and achieve efficiencies in the worldwide marketplace.

Hear from senior executives and leading industry experts to explore these critical topics (and more) and build lasting and collaborative supply chain partnerships.

This unique conference will feature expert-led education sessions on:

•    The political and policy landscape shaping distribution in Europe and the U.S.;
•    Pharmaceutical product traceability/medicines verification efforts from a global perspective;
•    The development and role of biosimilars;
•    Value-based outcomes and reimbursement;
•    The financial outlook for the global pharmaceutical market; and,
•    The evolution of collaborative supply chain trading partnerships.

ExL’s 4th Technology Transfer for Biologics conference is the only educational event in the U.S. to focus on the project, facility, and partnership management skills needed to maintain biologics quality at every step of process transfer and scale-up. No other event covers this subject in as much depth.

This year’s show features an all-new lineup of case studies to help you guarantee the reliability of your supply chain to U.S. and emerging markets, while also accelerating late-stage biologics development and exploring advancements in single-use technologies and commercialization software.

Top Five Reasons to Attend
 

• Special emphasis on planning process transfers to emerging markets
• Tools to identify and manage outsourced manufacturing partners
• Detailed strategies for avoiding the greatest challenges to successful transfers
• Multiple examples of adding Quality by Design principles into new transfers
• An in-depth interactive workshop on eliminating risks and accelerating project timelines

ExL Pharma’s European Trial Master File Summit continues to be the #1 source of information and replicable best practices in the life science industry. The quality and immediate relevance of topics are rivalled only by the calibre and zeal of our expert speaking faculty as well as the enthusiasm of participants at the event each year — and there is good reason for this.

This conference is by and for TMF™ professionals who play an active role in the identification and development of topics prior to the event. This event features a balance of:

    Select case studies vetted for relevance and scrutinised for poignancy
    Facilitated and informal peer-to-peer learning opportunities
    Broadly representative panels with complementary viewpoints
    Interactive sessions and workshops
    Industry leaders, preeminent experts, solution providers

ConferenceSeries Ltd invites all the participants across the globe to attend 12th World  Pharma Congress during October 16-18, 2017 Budapest, Hungary. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Congress 2017 is a specially designed cluster Pharma conference. The main theme of this Pharma conferences is “Current Technologies & Advancements In Pharmaceutical Field’’. The Impact of developing and Marketing Drugs, its Registration & Approval” which covers a wide range of critically important sessions.

The 15th Annual CTS East Coast event builds on last year’s conference, Arena’s biggest East Coast CTS event to date. To do this we have added a one day stream covering the emergence and adoption of innovative technology to find solutions for your clinical trial supply problems, whilst also offering a larger variety of sessions covering all the essentials in clinical supply, from maximising forecasting software to managing a yo-yoing workforce and uncovering what is driving supply outsourcing.

Key agenda highlights 2017:
•    Exploring how working with preferred partners to establish development standards can improve your use of IRT
•    Customizing current technologies to improve pharmaceutical supply chain management and improve efficiency
•    Uncovering what is driving supply outsourcing; how and why are traditionally in-house capabilities being externalized
•    Exploring what supply chain complexities arise from using biologics

Key Speakers 2017
•    Carla Reis, Senior Manager of IRT/Randomization, Bristol-Myers Squibb
•    Rey Bacchus, Clinical Trial Supply Manager, Janssen
•    Rocco Barone, Associate Director Operations, Merck
•    Brian Rogers, Packaging Project Management Head, Sanofi
•    Anthony Orosz, Assistant Director, Pharmaceutical, Health and Chemical Center of Excellence and Expertise, US Customs and Border Protection

Taking place 18-19th October in Hamburg, LogiMed is Europe’s only dedicated medical device supply chain event bringing together over 150 Medical Device Supply Chain Professionals to network with. With a greater focus on customer collaboration and digital transformation this year’s LogiMed delivers real insights on inventory visibility, supply chain planning, global logistics and digitalization.

Over 2 inspiring days, learn from best-in-class case studies, engage in thought-provoking debates and share your pain points in small, interactive peer-to-peer working groups.

Download the latest agenda now: http://bit.ly/2sZKGee